Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 4,710.00
-200.00 (-4.07%)
Feb 19, 2025, 9:00 AM KST
Prestige Biologics Revenue
Prestige Biologics had revenue of 3.02B KRW in the quarter ending December 31, 2024, with 302.65% growth. This brings the company's revenue in the last twelve months to 3.87B, up 5,496.88% year-over-year. In the fiscal year ending June 30, 2024, Prestige Biologics had annual revenue of 2.17B with 24.24% growth.
Revenue (ttm)
3.87B
Revenue Growth
+5,496.88%
P/S Ratio
75.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
343.73B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 57.73T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Celltrion | 2,876.25B |
| Kia Corporation | 104.63T |
| NAVER | 10.39T |